PITTSBURGH, Dec. 21,
2023 /PRNewswire/ -- Viatris Inc. (NASDAQ:
VTRS), a global healthcare company, today announced the company
will participate in the 42nd Annual J.P. Morgan
Healthcare Conference in San
Francisco on Wednesday, January 10,
2024. Chief Executive Officer Scott
A. Smith, President Rajiv
Malik and Chief Financial Officer Sanjeev Narula will represent the company in a
presentation followed by a fireside chat scheduled at 10:30 a.m. PST / 1:30 p.m.
ET.
Interested parties can access a live webcast of the event at
investor.viatris.com. An archived version also will be available
following the live event and can be accessed at the same location
for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global
healthcare company uniquely positioned to bridge the traditional
divide between generics and brands, combining the best of both to
more holistically address healthcare needs globally. With a mission
to empower people worldwide to live healthier at every stage of
life, we provide access at scale. In 2022 alone, we supplied
high-quality medicines to approximately 1 billion patients around
the world. With our exceptionally extensive and diverse portfolio
of medicines, a one-of-a-kind global supply chain designed to reach
more people when and where they need them, and the scientific
expertise to address some of the world's most enduring health
challenges, access takes on deep meaning at Viatris. We have the
ability to touch all of life's moments, from birth to end of life,
acute conditions to chronic diseases. We are headquartered in the
U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more
at viatris.com and investor.viatris.com, and connect with us
on Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-42nd-annual-jp-morgan-healthcare-conference-302021303.html
SOURCE Viatris Inc.